These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31503152)

  • 41. An exploratory analysis on the influence of genetic variants on weight gain among etonogestrel contraceptive implant users.
    Lazorwitz A; Dindinger E; Harrison M; Aquilante CL; Sheeder J; Teal S
    Contraception; 2020 Sep; 102(3):180-185. PubMed ID: 32407811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrasonographic features of the endometrium and the ovaries in women on etonogestrel implant.
    Van den Bosch T; Donders GG; Riphagen I; Debois P; Ameye L; De Brabanter J; Van Huffel S; Van Schoubroeck D; Timmerman D
    Ultrasound Obstet Gynecol; 2002 Oct; 20(4):377-80. PubMed ID: 12383321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tamoxifen for the Treatment of Etonogestrel Implant-Associated Bleeding in an Adolescent Gynecology Practice.
    Friedman JC; Buyers E; Laurin J; Hampanda K; Alaniz VI
    J Pediatr Adolesc Gynecol; 2022 Jun; 35(3):341-345. PubMed ID: 34780932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
    Moeti DMP; Govender I; Bongongo T
    S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tamoxifen for the treatment of breakthrough bleeding with the etonogestrel implant: a randomized controlled trial.
    Simmons KB; Edelman AB; Fu R; Jensen JT
    Contraception; 2017 Feb; 95(2):198-204. PubMed ID: 27725164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Etonogestrel Subdermal Implant-Associated Regression of Endometrial Intraepithelial Neoplasia.
    Wong S; Naresh A
    Obstet Gynecol; 2019 Apr; 133(4):780-782. PubMed ID: 30870304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
    Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
    Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variability in repeat serum etonogestrel concentrations among contraceptive implant users during the steady-release pharmacokinetic period.
    Lazorwitz A; Sheeder J; Teal S
    Contraception; 2022 Apr; 108():65-68. PubMed ID: 34973207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An exploratory study on the possible association of serum etonogestrel concentrations with mood concerns and symptoms among contraceptive implant users.
    Diamond B; Sheeder J; Lazorwitz A
    Contraception; 2024 Jan; 129():110298. PubMed ID: 37802462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene expression associated with unfavorable vaginal bleeding in women using the etonogestrel subdermal contraceptive implant: a prospective study.
    Torelli FR; Rodrigues-Peres RM; Monteiro I; Lopes-Cendes I; Bahamondes L; Juliato CRT
    Sci Rep; 2024 May; 14(1):11062. PubMed ID: 38745005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon.
    Wenzl R; van Beek A; Schnabel P; Huber J
    Contraception; 1998 Nov; 58(5):283-8. PubMed ID: 9883383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: A pharmacokinetic and pharmacodynamic study.
    Lazorwitz A; Sheeder J; Teal S
    Contraception; 2023 Jul; 123():110035. PubMed ID: 36997081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled Trial.
    Zigler RE; Madden T; Ashby C; Wan L; McNicholas C
    Obstet Gynecol; 2018 Oct; 132(4):888-894. PubMed ID: 30130351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year.
    Morrell KM; Cremers S; Westhoff CL; Davis AR
    Contraception; 2016 Mar; 93(3):263-5. PubMed ID: 26577754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contraceptive Implant-Associated Bleeding in Adolescent/Young Adult Clinical Practice: Associated Factors, Management, and Rates of Discontinuation.
    Milliren CE; DiVasta AD; Edwards AJ; Maslyanskaya S; Borzutzky C; Pitts S
    J Adolesc Health; 2023 Apr; 72(4):583-590. PubMed ID: 36599757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of bleeding irregularities among etonogestrel implant users: Is combined oral contraceptives pills or nonsteroidal anti-inflammatory drugs the better option?
    Upawi SN; Ahmad MF; Abu MA; Ahmad S
    J Obstet Gynaecol Res; 2020 Mar; 46(3):479-484. PubMed ID: 31958877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G; Kohlmeier L; Brenner H
    Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users.
    Mansour D; Bahamondes L; Critchley H; Darney P; Fraser IS
    Contraception; 2011 Mar; 83(3):202-10. PubMed ID: 21310280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.